BioCentury
ARTICLE | Clinical News

Amylin data

June 21, 1993 7:00 AM UTC

Amylin Pharmaceuticals Inc. Amylin Pharmaceuticals Inc. said that AC137, a modified form of the hormone amylin, was safe in single doses in Phase I studies. The three studies, two in non-diabetic vo...